AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇹🇳
OCRELIZUMAB in Tunisia
1 product registered with DPM — 0 active, 1 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| OCREVUS Solution injectable pour perfusion / 300 mg | 6993221H | Roche Pharma (Schweiz) AG | expired | 12 Jun 2020 |
OCRELIZUMAB — DPM Registration Details
DPM (Tunisia) has 1 registered product containing OCRELIZUMAB, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.
Track OCRELIZUMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.